Ambrx Biopharma Inc ADR (AMAM)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
28.00 +0.02 (+0.07%) 03/06/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 28.00 unch (unch) -
for Wed, Mar 6th, 2024
Results
download Want to compare other data? Select Fields| Symbol | AMAM | LGND | BLTE | ||
| Company | Ambrx Biopharma Inc ADR | Ligand Pharm | Belite Bio Inc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.99 | 95.24 | 53.11 | ||
| High | 28.00 | 106.35 | 54.40 | ||
| Low | 27.98 | 93.58 | 49.00 | ||
| Last | 28.00 | 103.29 | 53.99 | ||
| Change | +0.02 | +6.62 | -0.11 | ||
| % Change | +0.07% | +6.85% | -0.20% | ||
| Volume | 1,439,600 | 94,391 | 62,988 | ||
| 20-Day Average Volume | 1,545,680 | 136,070 | 37,017 | ||
| Previous Close | 27.98 | 96.67 | 54.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 27.86 | 106.13 | 64.36 | ||
| 20-Day Raw Stochastic | 94.23% | 57.77% | 22.28% | ||
| 20-Day Relative Strength | 80.97% | 46.17% | 33.84% | ||
| Weighted Alpha | +89.90 | +19.92 | +27.24 | ||
| Today's Opinion | 100% Buy | 56% Sell | 24% Sell | ||
| Previous Opinion | 100% Buy | 56% Sell | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 02/28/24 | -3.62% since 04/02/25 | -17.53% since 04/02/25 | ||
| Low | 27.93 on 03/01/24 | 93.60 on 04/09/25 | 49.00 on 04/09/25 | ||
| High | 28.00 on 03/06/24 | 106.63 on 04/03/25 | 65.00 on 04/03/25 | ||
| 1-Month | |||||
| %Chg | +0.79% since 02/06/24 | -8.74% since 03/07/25 | -14.70% since 03/07/25 | ||
| Low | 27.51 on 02/20/24 | 93.60 on 04/09/25 | 49.00 on 04/09/25 | ||
| High | 28.03 on 02/26/24 | 112.98 on 03/17/25 | 70.99 on 03/13/25 | ||
| 3-Month | |||||
| %Chg | +132.75% since 12/06/23 | -5.23% since 01/08/25 | -3.65% since 01/08/25 | ||
| Low | 11.74 on 12/12/23 | 93.60 on 04/09/25 | 49.00 on 04/09/25 | ||
| High | 28.15 on 01/10/24 | 125.17 on 03/03/25 | 70.99 on 03/13/25 | ||
| 6-Month | |||||
| %Chg | +111.32% since 09/06/23 | +1.51% since 10/09/24 | -2.00% since 10/09/24 | ||
| Low | 6.55 on 10/23/23 | 93.60 on 04/09/25 | 49.00 on 04/09/25 | ||
| High | 28.15 on 01/10/24 | 129.90 on 11/07/24 | 86.53 on 11/14/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,768,200 | 1,861,380 | 1,722,435 | ||
| Shares Outstanding, K | 63,150 | 19,255 | 31,838 | ||
| Annual Sales | 7,400,000 | 167,130,000 | 0 | ||
| Annual Net Income | -78,000,000 | -4,030,000 | -36,140,000 | ||
| Last Quarter Sales | 1,120,000 | 42,810,000 | 0 | ||
| Last Quarter Net Income | -17,830,000 | -31,090,000 | -10,100,000 | ||
| 60-Month Beta | -1.92 | 1.07 | -1.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/09/23 | -1.64 on 02/27/25 | -0.32 on 03/17/25 | ||
| Latest Earnings Date | 04/04/24 | 05/06/25 | 05/12/25 | ||
| Most Recent Dividend | N/A | 2.500 on 04/03/07 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||